Table 3.

Health and economic outcomes for a city of 8.3 million individuals

Strategy	Clinical attack rate	Infections	Deaths	Deaths averted	Pre-pandemic costs (millions of $)	Pandemic intervention costs (millions of $)	Pandemic treatment costs (millions of $)	Normal healthcare expenditures (millions of $)	Total Costs (millions of $)	QALYs* gained	Incremental cost-effectiveness ratio ($ per QALY)
Expanded adjuvanted vaccination	11%	889,908	21,882	45,941	306	203	188	1,498,439	1,501,284	404,030	10,844†
Expanded antiviral prophylaxis	17%	1,429,934	35,077	32,745	455	66	301	1,496,074	1,500,339	282,329	Dominated‡
Stockpiled strategy	19%	1,547,648	38,061	29,761	75	34	326	1,495,532	1,499,704	258,342	8,907§
No intervention	33%	2,739,242	67,822		-	-	582	1,490,164	1,497,403	-	-

^*QALY = quality-adjusted life-year

^†Incremental to stockpiled strategy

^‡Expanded adjuvanted vaccination provides more QALYs at a lower incremental cost effectiveness ratio

^§Incremental to no intervention